Stipend and Dates

Up to $8,300. (Multiple payments)

Note: You cannot pick which cohort you go into. The 1st cohort is filled before patients are placed in the next cohort. Cohort 1B Cohort 1C - Screening is ongoing. Dates to be determined.
Day -2 Admit May 23, 2022 Mon  
*Holter monitoring starts Day -1 to Day 5 (No electronics or cell phones)    
Day 5 Discharge (a payment within 10 business days after this day is completed) May 29, 2022 Sun  
Day 7 Outpatient Visit May 31 Tue  
Day 10 Outpatient Visit Jun 03 Fri  
Day 15 Outpatient Visit Jun 08 Wed  
Day 22 Final Outpatient Visit (a payment within 10 business days after this day is completed) Jun 15 Wed  


Click here to make an appointment for NO 0009-0625 Part A

Or call 210-225-5437 for more information

Study Criteria

Healthy non-smoking overweight Males and Females

Age:  18-55

BMI: 25.0 to 34.9 kg/m2


Study Information

Indication: The investigational drug is being developed as a potential treatment for overweight and / obesity.

Route of Administration: Oral

Washout from previous study: Participation in any clinical study within 30 days before receiving study drug in this study.

Acceptable Birth Control for Females (if Childbearing):  Females of child bearing potential must agree to use a highly effective method of contraception during the study treatment period and until 19 days after the end of the study. Highly effective methods of contraception are listed below:

  • Intrauterine device with male condoms
  • Intrauterine system with male condoms
  • Partner has had a Vasectomy (confirmed by the absence of sperm)
  • Stable Hormonal contraception with approved oral, intravaginal, transdermal, injectable or implantable (and male condoms).
  • Bilateral tubal occlusion/ligation
  • Sexual Abstinence

Females in the following categories are considered non-childbearing:

  • Documented total hysterectomy (removal of uterus), bilateral salpingectomy (removal of both Fallopian tubes), or bilateral oophorectomy (removal of both ovaries)
  • Menopause more than 12 months prior to study entry (stopped having monthly menstrual periods more than 12 months ago).
  • Greater than or equal to 60 years of age

The male participant should use a condom during study treatment and until the end of study.


Study Reminders

  • 8 hours fasting is required for lab work (only water is allowed)
  • If taking medications, bring them to your screening appointment (including prescription, over the counter, herbal supplements and vitamins)
  • Bring a valid, non-expired photo ID with you when you attend your screening visit.  We accept a valid government issued identification card such as a driver's license, state issued ID card or passport.  You will be required to show this same photo ID at all study visits
  • Arrive 30 minutes before your appointment to complete paper work.
NO 0009-0625 Part A
Healthy Adults
Male or Female
Payment amount
Up to $8,300
18 - 55